65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award

Active Awarded Last action

Contract number
36F79723D0228
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • 65IB Solicitation number
Last date to order 62% complete
IDV ceiling
$3,000,000.00
Award type
Multiple award
Who can order
All agencies
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

GSA awarded a Federal Supply Schedule contract for pharmaceuticals and drugs to Mission Pharmacal Company under Schedule 65 I B on September 15, 2023, with a contract ceiling of $3 million and period of performance through September 14, 2028. The contractor is approved to supply drugs, pharmaceuticals, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) schedule. This is a multiple-award vehicle with no set-aside category. Mission Pharmacal Company holds authorization to distribute specialty pharmaceutical items including NDC 44523-0055-01 under a dual-price structure. The contract serves the federal supply community through GSA's catalog-based ordering process, allowing agencies to place orders against the established price list without conducting individual competitions.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00013 · 42-2A | product addition - dual price | specialty distribution item | 1 NDC (44523-0055-01) | specialty distribution item $0
Other Administrative Action P00012 · Admin changes | 1 change - addresseses $0
Supplemental Agreement for work within scope P00011 · Life cycle change | PL-temporary to permanent | 2 ndcs of tinidazole: 44523-0450-12 & 44523-0450-20 $0
Supplemental Agreement for work within scope P00010 · 2026 public law pricing updates $0
Supplemental Agreement for work within scope P00009 · Addition - 2 ndcs of tinidazole (44523-0450-12 & 44523-0450-20) $0
Supplemental Agreement for work within scope P00008 · Life cycle change (PL-temporary to permanent) $0
Supplemental Agreement for work within scope P00007 · Addition - 1 NDC (44523-0415-01) - potassium citrate $0
Supplemental Agreement for work within scope P00006 · Addition $0
Supplemental Agreement for work within scope P00005 · 2025 public law price update(s) $0
Supplemental Agreement for work within scope P00004 · Deletion. $0
Other Administrative Action P00003 · Add POC. $0
Supplemental Agreement for work within scope P00002 · Permanent price decrease. $0
Supplemental Agreement for work within scope P00001 · PL updates. $0
Original award $0
Show all 14

Quick answers

Who was awarded contract 36F79723D0228?

36F79723D0228 was awarded to Mission Pharmacal Company by Veterans Integrated Service Network 12 (Veterans Health Administration) on September 15, 2023.

How much is contract 36F79723D0228 worth?

36F79723D0228's own ceiling is $3,000,000.

Who can order from contract 36F79723D0228?

36F79723D0228 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79723D0228 part of a contract vehicle?

Yes. 36F79723D0228 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79723D0228 competed?

The extent of competition for 36F79723D0228 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV